Building Toward Breakthroughs: Alzheimer’s Drug Discovery Foundation
FDA Approval of Adu: What does this mean for Alzheimer’s research and the patient community?
Howard Fillit, MD - Exec. Director & Chief Science Officer, Alzheimer's Drug Discovery Foundation
The Alzheimer's Disease Drug Development Pipeline: What's New & What's Coming w/ Dr. Jeff Cummings
Howard Fillit, MD: Alzheimer Disease Drug Development Improvement
Indiana University awarded $36 million grant for Alzheimer's drug discovery center
Virtual Great Ladies Event
Tenth Annual Melvin R. Goodes Prize
Coya Therapeutics (COYA) CEO on $5M Alzheimer’s Drug Discovery Foundation Investment
The Current State of Alzheimer’s Research
On the Front Lines of Alzheimer’s Research
Tomorrow's Breakthroughs Today: Phyllis Ferrell
ADDF Town Hall - May 2023
Tomorrow's Breakthroughs Today: Dr. Miranda Orr
Hope is Here - 25 Years of ADDF
Howard Fillit, MD & Ros Atkins - BBC World News July 20, 2017
Improving Phase II trials in AD drug development
A Special Thank You from the ADDF
Memories Matter: Randal Sandler
Doctors Discuss Alzheimer's Advancements